دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
National trends of utilization and readmission rates with intravascular ultrasound use for ST-elevation myocardial infarction
Lina Ya'qoub MD,Mohamed Gad MD,Anas M. Saad MD,Islam Y. Elgendy MD,Ahmed N. Mahmoud MD
doi : 10.1002/ccd.29524
Volume 98, Issue 1 p. 1-9
Randomized trials have confirmed that intravascular ultrasound (IVUS) guidance for percutaneous coronary interventions (PCI) improves long-term clinical outcomes. However, data on real-world utilization of IVUS in ST-elevation myocardial infarction (STEMI) and the impact on short to mid-term outcomes are scarce. We sought to evaluate the utilization and the readmission rates for IVUS-guided PCI in the setting of STEMI.
Intravascular ultrasound: Beneficial even with ST-segment elevation myocardial infarction
Arnold H. Seto MD, MPA, FSCAI, FACC,David M. Tehrani MD, MS
doi : 10.1002/ccd.29817
Volume 98, Issue 1 p. 10-11
Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States
Jayakumar Sreenivasan MD, MSc,Ahmed Abu-Haniyeh MD,Urvashi Hooda MD,Muhammad Shahzeb Khan MD,Wilbert S. Aronow MD,Erin D. Michos MD, MHS,Howard A. Cooper MD,Julio A. Panza MD
doi : 10.1002/ccd.29119
Volume 98, Issue 1 p. 12-21
To assess the causes and predictors of readmission after NSTEMI.
Preventing NSTEMI readmissions: Starting from the beginning
George W. Vetrovec MD, MSCAI
doi : 10.1002/ccd.29812
Volume 98, Issue 1 p. 22-23
Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial
Nirat Beohar MD,Shmuel Chen MD, PhD,Nicholas J. Lembo MD,Adrian P. Banning MD,Patrick W. Serruys MD, PhD,Martin B. Leon MD,Marie-Claude Morice MD,Philippe Généreux MD,David E. Kandzari MD,Arie Pieter Kappetein MD, PhD,Joseph F. Sabik III MD,Ovidiu Dressler MD,Thomas McAndrew PhD,Zixuan Zhang MS,Gregg W. Stone MD
doi : 10.1002/ccd.29116
Volume 98, Issue 1 p. 24-32
We examined outcomes according to lesion preparation strategy (LPS) in patients with left main coronary artery (LMCA) percutaneous coronary intervention (PCI) in the EXCEL trial.
Adequate preparation of complex left main lesions prior to stenting appears to level the playing field
Cindy L. Grines MD, MSCAI,Michele Voeltz MD, FSCAI
doi : 10.1002/ccd.29839
Volume 98, Issue 1 p. 33-34
Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single-center registry study
Jonathan Luke Murphy MD,Nileshkumar Patel MD,Yuliya Vengrenyuk PhD,Naotaka Okamoto MD,Nitin Barman MD,Joseph Sweeny MD,Vishal Kapur MD,Choudhury Hasan MD,Prakash Krishnan MD,Pooja Vijay BS,Vaishvi Jhaveri BS,George Dangas MD, PhD,Roxana Mehran MD,Melissa Aquino MS,Usman Baber MD,Samin K. Sharma MD,Annapoorna S. Kini MD
doi : 10.1002/ccd.29069
Volume 98, Issue 1 p. 35-42
Both target vessel calcification and target vessel bifurcation are associated with worse outcomes following percutaneous coronary intervention (PCI). Whether these entities in combination interact to influence outcomes after PCI of complex coronary disease is not known.
The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
Yuxiang Dai MD,Junbo Ge MD, PhD
doi : 10.1002/ccd.29818
Volume 98, Issue 1 p. 43-44
Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study
Luc Maillard MD, PhD,Axel de Labriolle MD, PhD,Camille Brasselet MD, PhD,Benjamin Faurie MD,Nicolas Durel MD,Fabien de Poli MD,Sébastien Bosle MD,Hend Madiot CRA,Jacques Berland MD,Loic Belle MD
doi : 10.1002/ccd.29065
Volume 98, Issue 1 p. 45-54
The Cobra PzF coronary stent is cobalt chromium with flat thin struts, nano-coated with Polyzene-F that enhance rapid reendothelialization and reduce the risk of stent thrombosis and restenosis. It is designed to overcome shortfalls of BMS and DES in patients requiring short DAPT duration.
The death knell of bare metal stents: The Cobra stent's encouraging results with short-term antiplatelet therapy
Nachiket J. Patel MD,Richard R. Heuser MD
doi : 10.1002/ccd.29813
Volume 98, Issue 1 p. 55-56
Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population
Sandeep Basavarajaiah MD, MRCP, FESC,Sampath Athukorala MD, MRCP,Konstantinos Kalogeras MD, MRCP,Vasileios Panoulas MD, MRCP,Bhagya H. Loku Waduge MBBS,Gurbir Bhatia MD, MRCP,Richard Watkin MD, MRCP, FESC,George Pulikal MD, MRCP,Kaeng Lee MD, MRCP,Jerome Ment MD, MRCP,Bethan Freestone MD, MRCP,Michael Pitt MD, MRCP
doi : 10.1002/ccd.28998
Volume 98, Issue 1 p. 57-65
Use of drug coated balloons (DCBs) in coronary intervention is escalating. There is a plethora of data on Paclitaxcel-DCB. However, when it comes of stents, Limus-drugs are preferred over Paclitaxel. There is very limited data on Sirolimus coated balloons (SCB). MagicTouch-SCB (Concept Medical, FL) elutes Sirolimus via nano-technology and have been used in our centers since March 2018. We report a mid-term follow-up with this relatively novel-technology.
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials
Jorge Sanz S?nchez MD, PhD,Mauro Chiarito MD,Bernardo Cortese MD,Andrea Moretti MD,Paolo Pagnotta MD,Bernhard Reimers MD,Giulio G. Stefanini MD, PhD,Giuseppe Ferrante MD, PhD
doi : 10.1002/ccd.29111
Volume 98, Issue 1 p. 66-75
There is conflicting evidence about the effects of drug-coated balloons (DCB) compared with drug-eluting stents (DES) in patients with native small vessel coronary artery disease (CAD).
Impact of a contrast media volume control device on acute kidney injury rate in patients with acute coronary syndrome
Carlo Briguori MD, PhD,Marco Golino MD,Nicola Porchetta MD,Mario Scarpelli MD,Francesca De Micco MD,Carmine Rubino RN,Amelia Focaccio MD,Giuseppe Signoriello PhD
doi : 10.1002/ccd.29136
Volume 98, Issue 1 p. 76-84
The DyeVert™ system (Osprey Medical Inc., Minnesota, MN) may reduce contrast media (CM) volume during coronary procedures while maintaining fluoroscopic image quality. Here, we assessed whether the use of the DyeVert system reduces acute kidney injury (AKI) rate in patients with acute coronary syndrome (ACS) undergoing invasive coronary procedures.
New DyeVert system for contrast media volume reduction in percutaneous procedures: “Make kidney safe again”
Giuseppe Tarantini MD, PhD,Francesco Cardaioli MD
doi : 10.1002/ccd.29810
Volume 98, Issue 1 p. 85-86
Ability of a novel shock index that incorporates invasive hemodynamics to predict mortality in patients with ST-elevation myocardial infarction
Alexander McKenzie MD, MPH,Cynthia Zhou MD,Christopher Svendsen BA,Rebecca Anketell BS,Arash Behroozi BS,Dafe Jessa MS,Charles Piehl BS,Robert Rayson MD,Michael Yeung MD,George A. Stouffer MD
doi : 10.1002/ccd.29460
Volume 98, Issue 1 p. 87-94
To determine whether the use of invasively measured hemodynamics improves the prognostic ability of a shock index (SI).
Shock indices in acute myocardial infarction
George D. Dangas MD, PhD,Matthew I. Tomey MD
doi : 10.1002/ccd.29808
Volume 98, Issue 1 p. 95-96
#SoMe for #IC: Optimal use of social media in interventional cardiology
Andrew M. Goldsweig MD, MS,Benjamin Z. Galper MD, MPH,Chadi Alraies MD,Suzanne V. Arnold MD, MHA,Matthew Daniels MD, PhD,Davide Capodanno MD, PhD,Giuseppe Tarantini MD, PhD,David J. Cohen MD, MSc,Herbert D. Aronow MD, MPH
doi : 10.1002/ccd.29643
Volume 98, Issue 1 p. 97-106
Social media allows interventional cardiologists to disseminate and discuss research and clinical cases in real-time, to demonstrate and learn innovative techniques, to build professional networks, and to reach out to patients and the general public. Social media provides a democratic platform for all participants to influence the conversation and demonstrate their expertise. This review addresses the use of social media for these purposes in interventional cardiology, as well as respect for patient privacy, how to get started on social media, the creation of high-impact social media content, and the role of traditional journals in the age of social media. In the future, we hope that interventional cardiology fellowship programs will incorporate social media training into their curricula. In addition, professional societies may adapt to the rapid dissemination of data on social media by developing processes to update guidelines more rapidly and more frequently.
Systematic review of the evaluation and management of coronary pseudoaneurysm after stent implantation
Atif Hassan MD,Barry F. Uretsky MD,Andres M. Vargas Estrada MD,Romesa Hassan MD,Malek Al-Hawwas MD,Shiv Kumar Agarwal MD
doi : 10.1002/ccd.29312
Volume 98, Issue 1 p. 107-116
Pseudoaneurysm (PSA) formation is a rare but well-known complication of coronary stenting. It develops after a procedural perforation disrupts the integrity of the vessel wall but is contained by a single wall layer, usually pericardium, extravascular thrombosis and later fibrosis. Medical literature of PSA consists primarily of case reports. A systematic review of pseudoaneurysm after coronary stenting was performed to summarize its presentation, diagnostic imaging modalities, natural history, and management approaches. Clinical presentations range from asymptomatic to hemodynamic collapse, size from small to “giant,” and treatment approaches from surgical or percutaneous exclusion to “watchful waiting” and imaging surveillance. Based on current information, a management algorithm is provided recommending urgent to emergent exclusion for symptomatic PSA, elective exclusion for large and giant PSA, and “watchful waiting” and periodic imaging surveillance for small to moderate sized PSA.
Preliminary testing and evaluation of the renata minima stent, an infant stent capable of achieving adult dimensions
Evan M. Zahn MD, FACC, MSCAI,Eason Abbott BS,Neil Tailor MD,Shyam Sathanandam MD,Dustin Armer BS
doi : 10.1002/ccd.29706
Volume 98, Issue 1 p. 117-127
This study sought to obtain in vivo data on a new stent and delivery system specifically designed for implantation in infants with the ability to be enlarged to adult dimensions.
Correction of sinus venosus atrial septal defects with the 10 zig covered Cheatham-platinum stent – An international registry
Eric Rosenthal MD, FRCP,Shakeel A. Qureshi MD, FSCAI,Matthew Jones MBBS,Gianfranco Butera MD, PhD,Kothandam Sivakumar MD, DM,Younes Boudjemline MD, PhD,Ziyad M. Hijazi MSCAI,Salim Almaskary MD,Reid D. Ponder BS,Morris M. Salem MD, FSCAI,Kevin Walsh MD,Damien Kenny MD, FSCAI,Sebastien Hascoet MD,Darren P. Berman MD, FSCAI,John Thomson MD, FSCAI,Joseph J. Vettukattil MBBS,Evan M. Zahn MD, MSCAI
doi : 10.1002/ccd.29750
Volume 98, Issue 1 p. 128-136
Covered stent correction of sinus venosus ASDs (SVASD) is a relatively new technique. Challenges include anchoring a sufficiently long stent in a nonstenotic superior vena cava (SVC) and expanding the stent at the wider SVC-RA junction without obstructing the anomalous right upper pulmonary vein (RUPV). The 10-zig covered Cheatham-platinum (CCP) stent has the advantage of being available in lengths of 5–11?cm and dilatable to 34?mm in diameter.
Gettin' Ziggy with it
Steven Liskov MD,William A. Gray MD
doi : 10.1002/ccd.29816
Volume 98, Issue 1 p. 137-138
Can a self-expanding pediatric stent expand with an artery? Relationship of stent design to vascular biology
Nima V. Nia MS,Gregory A. Fishbein MD,Daniel S. Levi MD
doi : 10.1002/ccd.29679
Volume 98, Issue 1 p. 139-147
A large-diameter, intravascular, self-expanding stent system capable of continued expansion during somatic and vascular growth was modeled with finite element analysis (FEA), manufactured and tested in an animal model.
Racial disparities in the treatment of aortic stenosis: Has transcatheter aortic valve replacement bridged the gap?
Ikenna Erinne MD,Ankur Sethi MBBS, FACC,Justin Johannesen MD,John Kassotis MD Eng Sci D, FACP, FACC, FHRS
doi : 10.1002/ccd.29487
Volume 98, Issue 1 p. 148-156
Racial disparities in outcomes and utilization of surgical aortic valve replacement (SAVR) for the treatment of severe aortic stenosis (AS) is well known. While transcatheter aortic valve replacement (TAVR) has become more widespread, its impact on racial disparities remains unclear.
Transcatheter aortic valve replacement has not helped bridge the racial disparity gap
Alexander Postalian MD,Zvonimir Krajcer MD
doi : 10.1002/ccd.29814
Volume 98, Issue 1 p. 157-158
Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease
Hope Caughron MD,Devang Parikh MD,Zev Allison MD,Tobias Deuse MD,Vaikom S. Mahadevan MD
doi : 10.1002/ccd.29559
Volume 98, Issue 1 p. 159-167
This study evaluates in-hospital, 30-day, and 1-year outcomes post-transcatheter aortic valve replacement (TAVR) in end stage liver disease (ESLD) and/or end stage renal disease (ESRD) compared with patients without these comorbidities.
TAVR in patients with end stage liver and renal disease: Lifesaving and increasing transplant eligibility
Mehmet Cilingiroglu MD,Sercan Okutucu MD
doi : 10.1002/ccd.29809
Volume 98, Issue 1 p. 168-169
Elective versus urgent in-hospital transcatheter aortic valve implantation
Alex Kabahizi MBChB, MRCP, MSc IHM,Azeem S. Sheikh MBBS, FCPS, MRCP, PG Cert,Timothy Williams MBBS, MRCP,Kristoffer Tanseco MD, MRCP,Aung Myat BSc (Hons), MBBS, MRCP, MD (Res),Uday Trivedi BSc (Hons), MBBS, FRCS(C-Th), MSc FELTS,Adam de Belder BSc, MD, FRCP,James Cockburn BSc (Hons), MBBS, MRCP, MD,David Hildick-Smith MD, FRCP, FSCAI
doi : 10.1002/ccd.29638
Volume 98, Issue 1 p. 170-175
Transcatheter aortic valve implantation (TAVI) is maturing as a treatment option and is now often undertaken during an unscheduled index hospital admission. The aim of this study was to look at procedural and mid-term outcomes of patients undergoing elective versus urgent in-hospital transcatheter aortic valve implantation.
Sex-specific in-hospital outcomes of transcatheter aortic valve replacement with third generation transcatheter heart valves
Trevor Simard MD,Fahad Alqahtani MD,Benjamin Hibbert MD,Mamas A. Mamas MD,Stephanie El-Hajj MD,Alyssa H. Harris MPH,Samuel F. Hohmann PhD,Mohamad Alkhouli MD
doi : 10.1002/ccd.29499
Volume 98, Issue 1 p. 176-183
Sex-based differences in transcatheter aortic valve replacement (TAVR) outcomes have been previously documented. However, whether these differences persist with contemporary third generation transcatheter heart valves (THVs) is unknown.
Equality in matters of the heart?
Prakash Balan MD,Marvin H. Eng MD
doi : 10.1002/ccd.29815
Volume 98, Issue 1 p. 184-184
Association between mid-term worsening renal function and mortality after transcatheter aortic valve replacement in patients with chronic kidney disease
Derek Q. Phan MD,Ming-Sum Lee MD, PhD,Vicken Aharonian MD,Prakash Mansukhani MD,Naing Moore MD,Somjot S. Brar MD, MPH,Ray Zadegan MD
doi : 10.1002/ccd.29429
Volume 98, Issue 1 p. 185-194
Chronic kidney disease (CKD), acute kidney injury (AKI) and worsening renal function at 30?days after transcatheter aortic valve replacement (TAVR) portend poor outcomes. We sought to evaluate the association between worsening renal function at 3–6 months and mortality among patients with baseline renal dysfunction undergoing TAVR.
Worsening renal function after transcatheter aortic valve replacement: Infrequent but deleterious
Islam Y. Elgendy MD,Hani Jneid MD
doi : 10.1002/ccd.29811
Volume 98, Issue 1 p. 195-196
BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients
Stefan Verheye MD, PhD,Adrian Wlodarczak MD,Piero Montorsi MD,Jan Torzewski MD,Johan Bennett MD, PhD,Michael Haude MD,Gregory Starmer MD,Thomas Buck MD,Marcus Wiemer MD,Amin A. B. Nuruddin MD,Bryan P.-Y. Yan MD,Michael K.-Y. Lee MD
doi : 10.1002/ccd.29260
Volume 98, Issue 1 p. E1-E8
We aimed to assess the safety and performance of the Magmaris sirolimus-eluting bioresorbable magnesium scaffold in a large patient population.
Standardized fractal bench test evaluation of coronary stents: Performances in bifurcation lesions treated by the re-proximal optimization technique
Pierre-Guillaume Piriou MD,Mickael Bonin MD,Francois Huchet MD,Vincent Letocart MD,Thibaut Manigold MD,Julien Plessis MD,Francois Derimay MD, PhD,Joelle Veziers PhD,Fabienne Jordana PhD,Patrice Guerin MD, PhD
doi : 10.1002/ccd.29288
Volume 98, Issue 1 p. E9-E17
Bifurcation lesions in coronary arteries are complex to treat with coronary stents, which are not designed for that purpose and can be unproperly deployed. Moreover, devices are constantly evolving, and so are angioplasty techniques.
Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis
Francesco Bruno MD,Fabrizio D'Ascenzo MD, PhD,Giorgio Marengo MD,Roberto Manfredi MD,Andrea Saglietto MD,Guglielmo Gallone MD,Luca Franchin MD,Francesco Piroli MD,Filippo Angelini MD,Ovidio De Filippo MD,Federico Conrotto MD,Pierluigi Omedè MD,Antonio Montefusco MD,Mauro Pennone MD,Massimo Boffini MD,Marco Pocar MD,Mauro Rinaldi MD,Gaetano Maria De Ferrari MD
doi : 10.1002/ccd.29427
Volume 98, Issue 1 p. E18-E23
Clinical benefits of FFR (Fraction Flow Reserve) driven CABG (Coronary Artery Bypass Graft) remain to be established.
Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry
Yusuke Watanabe MD,Satoru Mitomo MD,Toru Naganuma MD,Kensuke Takagi MD,Hiroaki Obata,Alaide Chieffo MD,Matteo Montorfano MD,Sunao Nakamura MD, PhD,Antonio Colombo MD
doi : 10.1002/ccd.29431
Volume 98, Issue 1 p. E24-E34
We assessed the impact of pre-percutaneous coronary intervention (PCI) bifurcation angle change (BAC) on clinical outcomes.
Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease
Koji Sogabe MD,Masahiro Koide MD,Kento Fukui MD,Yukinori Kato MD,Hiroki Kitajima MD,Satoshi Akabame MD,Kan Zen MD,Takeshi Nakamura MD,Satoaki Matoba MD
doi : 10.1002/ccd.29435
Volume 98, Issue 1 p. E35-E42
Paclitaxel-coated balloon angioplasty for de-novo coronary artery lesions causes late lumen enlargement (LLE), however, the mechanisms and predictors of LLE have not been elucidated.
Procedural optimization of drug-coated balloons in the treatment of coronary artery disease
Hak Seung Lee MD,Jeehoon Kang MD,Kyung Woo Park MD, PhD,You-Jeong Ki MD,Mineok Chang MD, PhD,Jung-Kyu Han MD, PhD,Han-Mo Yang MD, PhD,Hyun-Jae Kang MD, PhD,Bon-Kwon Koo MD, PhD,Hyo-Soo Kim MD, PhD
doi : 10.1002/ccd.29492
Volume 98, Issue 1 p. E43-E52
This study aimed to investigate the effects of procedural optimization on the clinical outcomes of using the drug-coated balloon (DCB) in the treatment of coronary artery disease.
Vascular complications associated with intraaortic balloon pump supported percutaneous coronary intervention (PCI) and clinical outcomes from the British Cardiovascular Intervention Society National PCI Database
Tim Kinnaird MD,Richard Anderson MD,Sean Gallagher MD,Andrew S. P. Sharp PhD,Vasim Farooq MD,Peter Ludman MD,Samuel Copt PhD,Nicholas Curzen PhD,Alex Sirker MD,Jim Nolan MD,Mamas Mamas DPhil
doi : 10.1002/ccd.29549
Volume 98, Issue 1 p. E53-E61
The impact of a vascular complication (VC) in the setting of intraaortic balloon pump (IABP) supported PCI on clinical outcomes is unclear.
The incidence, natural history, and predictive factors for tissue protrusion after drug-eluting stent implantation
Munemitsu Otagaki MD,Kenichi Fujii MD, PhD,Koichiro Matsumura MD, PhD,Teppei Noda MD,Hiroki Shibutani MD,Kenta Hashimoto MD,Shun Morishita MD,Satoshi Tsujimoto MD, PhD,Yoshihiro Yamamoto MD, PhD,Haengnam Park MD, PhD,Kei Yoshioka MD, PhD,Ichiro Shiojima MD, PhD
doi : 10.1002/ccd.29551
Volume 98, Issue 1 p. E62-E68
Although tissue protrusion (TP) between the stent struts after stent implantation has been implicate as a potential factor of stent failure, the incidence, natural history, and predictive factor of TP after stent implantation remains unclear. This prospective study evaluated the fate of TP after drug-eluting stent (DES) deployment using optical coherence tomography (OCT).
Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome
Alejandro Gutiérrez-Barrios MD, PhD,Livia Luciana Gheorghe MD,Santiago Camacho Freire MD,Etel Silva PhD,Antonio G?mez Menchero MD,Morales Ponce Francisco Jose MD,Dolores Ca?adas Prua?o MD,Uriel Mart?nez Capoccioni MD,Josep Gomez Lara MD, PhD,Teresa Bretones Del Pino MD, PhD,German Calle Perez MD
doi : 10.1002/ccd.29557
Volume 98, Issue 1 p. E69-E77
This study sought to evaluate the clinical outcomes of patients treated with magnesium-based bioresorbable scaffolds (MgBRS) in the context of acute coronary syndromes (ACS) at long-term follow-up (24?months). The study also aims to investigate the MgBRS performance by angiography and the healing and bioresorption pattern by optical coherence tomography (OCT) at 18?months.
Optimizing mechanical circulatory support hemodynamics using coronary sinus pacing
Hassan Tahir MD,Robert Tonks MD,James Cox MD, FACC,Raj Baljepally MD, FACC
doi : 10.1002/ccd.29537
Volume 98, Issue 1 p. E78-E84
The role of atrioventricular (AV) dyssynchrony as a cause of low Impella device output in cardiogenic shock from acute anterior myocardial infarction (MI) responding to reestablishing AV synchrony has not been previously reported. We present, for the first time, a unique case of AV dyssynchrony causing recurrent hypotension and ventricular fibrillation in such a patient, followed by immediate return to hemodynamic stability after restoring AV synchrony. Our case also highlights the novel use of a Damato multi-polar catheter for coronary sinus pacing to achieve AV synchrony.
A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry
Lorenzo Azzalini MD, PhD, MSc,Mauro Carlino MD
doi : 10.1002/ccd.29539
Volume 98, Issue 1 p. E85-E90
While antegrade techniques remain the cornerstone of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), operators have often to resort to the retrograde approach in complex occlusions. In particular, lesions with proximal cap ambiguity, unclear vessel course and/or poor distal landing zone are difficult to tackle with either antegrade wiring or antegrade dissection and re-entry (ADR), and often require the retrograde approach. After collateral channel crossing, the retrograde approach usually culminates with either reverse controlled antegrade and retrograde subintimal tracking (CART) or retrograde true lumen crossing. Both techniques usually involve the use of an externalization wire, which requires keeping a higher activate clotting time to prevent thrombosis of the retrograde channel and is potentially associated with risk for donor vessel injury. In 2018, we described antegrade fenestration and re-entry (AFR), a targeted ADR technique in which fenestrations between the false and true lumen are created by antegrade balloon dilatation in the extraplaque space at the level of the distal cap, which are subsequently engaged by a polymer-jacketed wire to achieve re-entry. We hypothesized that AFR can also expedite antegrade crossing of the CTO after a wire has reached the distal vessel in a retrograde fashion. In this report, we present two cases in which we successfully achieved antegrade CTO crossing with AFR following retrograde advancement of a guidewire to the distal cap, in new variant of the technique, which we called “facilitated AFR”.
Acute kidney injury in cardiogenic shock: A comprehensive review
Omar Sheikh MD,Tung Nguyen MD,Shweta Bansal MD, FASN,Anand Prasad MD, FACC, FSCAI, RPVI
doi : 10.1002/ccd.29141
Volume 98, Issue 1 p. E91-E105
Acute kidney injury (AKI) is an ominous predictor of mortality in cardiogenic shock. The present review examines the pathophysiology of AKI in cardiogenic shock (CS), summarizes the pertinent literature including the diagnostic criteria/definitions for AKI and possible role of biomarkers, and identifies risk factors and possible therapeutic interventions for AKI in CS. Our review finds that AKI is common in patients with CS and is associated with increased morbidity and mortality. Urinary biomarkers of renal tubular injury appear more sensitive for detection of AKI but have yet to be incorporated into daily practice. Emerging data would suggest vasopressor choices, mechanical circulatory support, and renal replacement therapy may have important therapeutic roles in the management of CS.
Anatomic burden mostly outperforms ischemic burden: From COURAGE to ISCHEMIA
Suraj Dahal MD,Matthew J. Budoff MD
doi : 10.1002/ccd.29513
Volume 98, Issue 1 p. E106-E107
Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation
Xavier Iriart MD,Patrice Guérin MD,Zakaria Jalal MD, PhD,Jean-Benoit Thambo MD, PhD
doi : 10.1002/ccd.29681
Volume 98, Issue 1 p. E108-E114
A 48-year-old who underwent a Mustard operation in 1972 followed by a second cardiac intervention in 1996 for pulmonary venous baffle enlargement and residual baffle leak closure, complicated by recurrent atrial flutter, was admitted to our institution for severe systemic atrio-ventricular valve regurgitation (SAVVR) associated with severely impaired systemic right ventricular (RV) function. After careful preoperative anatomic assessment including three-dimensional transesophageal echocardiography (3DTEE) to define the clipping strategy and computed tomography to optimize the transvenous baffle puncture site, the intervention was performed under general anesthesia, fluoroscopic, and 3DTEE guidance. One XTR MitraClip was successfully implanted, achieving a significant reduction in regurgitation and immediate clinical improvement. The transbaffle puncture was closed using an 8?mm atrial septal defect (ASD) device without residual shunt or obstruction of the venous baffle. Post-operative clinical evaluation showed immediate improvement in the NYHA functional class (from III to II), but the patient presented with recurrent flutter at 1?week after the procedure, which was successfully treated by catheter ablation with another transbaffle approach next to the ASD device. Clinical improvement was maintained at 1- and 6-month follow-up with significant reduction in SAVVR, reduced systemic RV volumes and improved RV ejection fraction. This case demonstrates the feasibility of percutaneous treatment of systemic SAVV in patients with systemic RV after atrial redirection.
CARotid plaqUe StabilizatiOn and regression with evolocumab: Rationale and design of the CARUSO study
Tiziana Claudia Aranzulla MD, MSc,Salvatore Piazza MD,Andrea Ricotti PhD, PharmD,Giuseppe Musumeci MD,Andrea Gaggiano MD
doi : 10.1002/ccd.29743
Volume 98, Issue 1 p. E115-E121
While the experience with PCSK9i in patients with coronary artery disease has been wide, and coronary plaque regression has been documented, little is known regarding the role of these drugs on carotid plaque regression. The CARotid plaqUe StabilizatiOn and regression with evolocumab (CARUSO) study is a randomized, single-center, investigator-initiated trial aiming at evaluating carotid plaque morphological stabilization and regression following, respectively, 6 and 12?months of therapy with evolocumab.
Management of dead space thrombosis during decannulation of peripherally inserted venoarterial extracorporeal membrane oxygenation
Dmitry S. Sulimov MD,Matthias Markuske MD,Steffen Desch MD,Holger Thiele MD
doi : 10.1002/ccd.29595
Volume 98, Issue 1 p. E122-E123
Ischemic complications after percutaneous decannulation of veno-arterial extracorporeal membrane oxygenation (va-ECMO) are not rare and can lead to significant morbidity or even mortality in case of delayed diagnosis or treatment. A possible cause of thromboembolic complications is the formation of thrombus between in the short segment between the large bore retrograde arterial cannula of va-ECMO and the antegrade limb perfusion sheath due to absence of blood flow (dead space). In this case report, we demonstrate a new technique of flushing the dead space to prevent embolic complications during va-ECMO decannulation.
Percutaneous deep venous arterialization at femoropopliteal segment for unhealed amputated stump ulcer after below the knee amputation
Shigeo Ichihashi MD,Yamato Tamura MD,Shinsaku Maeda MD,Kimihiko Kichikawa MD
doi : 10.1002/ccd.29693
Volume 98, Issue 1 p. E124-E126
Efficacy of percutaneous deep venous arterialization (pDVA) has been reported for patients with no-option chronic limb threatening ischemia. To date, the procedure has been limited for below the knee/below the ankle occlusive disease. The present report describes the pDVA performed at a femoropopliteal segment for a patient with a stump complication after below the knee amputation. The patient was a 70-year-old male who had a history of endovascular treatment in the right superficial femoral artery (SFA) and below knee amputation 6?years before. He had an unhealed ulcer at the amputated stump for 3?years. Computed tomography angiography demonstrated occluded right SFA, with a stenotic popliteal artery. Revascularization was considered unfeasible due to the absence of run off vessels. In order to improve the perfusion at the ulcer, pDVA was performed at the distal SFA level, bridging SFA and femoral vein using stent grafts. The final angiogram demonstrated the revascularized SFA connecting to popliteal vein with a brisk flow. After pDVA, the stump ulcer improved and the stent grafts were kept patent after 6 months of the procedure. pDVA at the SFA level was technically feasible and could be a useful approach for stump complication after below knee amputation.
Impact of baseline conduction abnormalities on outcomes after transcatheter aortic valve replacement with SAPIEN-3
Yasser Sammour MD,Kimi Sato MD,Arnav Kumar MD MSCR,Rama Dilip Gajulapalli MD,Hassan Lak MD,Sanchit Chawla MD,Kinjal Banerjee MD,Manpreet Kaur MD,Jay Patel MD,Cameron Incognito MD,Lars Svensson MD,Zoran Popovic MD,Khaldoun Tarakji MD,Oussama Wazni MD,Grant W Reed MD,James Yun MD,Rishi Puri MD,Amar Krishnaswamy MD,Samir R. Kapadia MD
doi : 10.1002/ccd.29309
Volume 98, Issue 1 p. E127-E138
Baseline conduction abnormalities are known risk factors for permanent pacemaker (PPM) implantation after transcatheter aortic valve replacement (TAVR). We sought to determine the impact of baseline right bundle branch block (RBBB), left bundle branch block (LBBB), left anterior hemiblock (LAHB), first-degree atrioventricular block (AVB) and atrial fibrillation/flutter (AF) on TAVR outcomes.
Contemporary transcatheter aortic valve implantation related thrombocytopenia
Haitham Abu Khadija MD,Omar Ayyad MD,Dan Haberman MD,Gera Gandelman MD,Lion Poles MD,Michael Jonas MD,Igor Volodarsky MD,Maher Abu Kweider MD,Alexander Maximovskih MD,Sara Shimoni MD,Jacob George MD,Alex Blatt MD, MSc
doi : 10.1002/ccd.29325
Volume 98, Issue 1 p. E139-E144
Transcatheter aortic valve implantation related thrombocytopenia (TAVI-rTP) is an inevitable phenomenon. However, no study has been performed on TAVI-rTP in the current setting of extended clinical indications combined with technology improvements.
One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system
Matteo Casenghi MD,Riccardo Gorla MD, PhD,Antonio Popolo Rubbio MD,Federico De Marco MD, PhD,Nedy Brambilla MD,Mauro Agnifili MD,Luca Testa MD, PhD,Francesco Bedogni MD
doi : 10.1002/ccd.29353
Volume 98, Issue 1 p. E145-E152
This study sought to investigate the procedural and mid-term outcomes of transcatheter aortic valve implantation for failed surgical bioprostheses (TAVI-ViV) with Portico device.
Transcatheter aortic valve replacement in aortic regurgitation: The U.S. experience
Shilpkumar Arora MD, MPH,Sopan Lahewala MD,Zachary Zuzek MD,Samarthkumar Thakkar MD,Chinmay Jani MD,Rahul Jaswaney MD,Aanandita Singh MBBS,Poonam Bhyan MD,Nirav Arora MS,Anthony Main MD,Mohammed Najeeb Osman MD,Brian D. Hoit MD,Guilherme F. Attizzani MD,Sidakpal S. Panaich MD
doi : 10.1002/ccd.29379
Volume 98, Issue 1 p. E153-E162
Transcatheter aortic valve replacement (TAVR) can be an effective option for high-risk Aortic Regurgitation (AR) patients. Although international experiences of TAVR for AR are published, U.S. data are limited. This study sought to report the short-term outcomes of TAVR in AR in the U.S. population.
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study)
Giulio Falasconi MD,Francesco Melillo MD,Luigi Pannone MD,Marianna Adamo MD,Federico Ronco MD,Azeem Latib MD,Kusha Rahgozar MD,Nazario Carrabba MD,Renato Valenti MD,Rodolfo Citro MD,Stefano Stella MD,Giacomo Ingallina MD,Cristina Capogrosso MD,Mara Scandroglio MD,Francesco Ancona MD,Cosmo Godino MD,Paolo Denti MD,Alessandro Castiglioni MD,Michele De Bonis MD,Antonio Colombo MD,Laura Lupi MD,Luca Branca MD,Matteo Montorfano MD,Eustachio Agricola MD
doi : 10.1002/ccd.29683
Volume 98, Issue 1 p. E163-E170
The aim of this study was to evaluate the impact of edge-to-edge PMVR on short and mid-term clinical outcomes in patients with CS and severe MR.
